These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 564259)

  • 21. [Farnesol and neuroleptics. II. Action of farnesol, alone or associated with a neuroleptic, on the stereotypies induced in the rat by amphetamine].
    Binet P; Miocque M; Roux M; Rinjard P
    Ann Pharm Fr; 1975; 33(6-7):321-8. PubMed ID: 1241259
    [No Abstract]   [Full Text] [Related]  

  • 22. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
    Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD
    Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. behavior of rats and mice administered active metabolites of fluphenazine, 7-hydroxy-fluphenazine and fluphenazine-sulfoxide.
    Yamada K; Furukawa T
    Arch Int Pharmacodyn Ther; 1980 Nov; 248(1):76-85. PubMed ID: 7194019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of the increase in apomorphine-induced stereotypy and aggression in REM sleep deprived rats by dopamine agonist pretreatments.
    Troncone LR; Ferreira TM; Braz S; Silveira Filho NG; Tufik S
    Psychopharmacology (Berl); 1988; 94(1):79-83. PubMed ID: 3126531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of radiation on the stereotyped behavior of rats caused by fenamin and apomorphine].
    Legeza VI; Kamynina MF; Markovskaia IV; Shagoian MG; Varshamov IuL
    Radiobiologiia; 1982; 22(6):829-31. PubMed ID: 6891474
    [No Abstract]   [Full Text] [Related]  

  • 26. Sensitization of amphetamine-induced stereotyped behaviors during the acute response.
    Kuczenski R; Segal DS
    J Pharmacol Exp Ther; 1999 Feb; 288(2):699-709. PubMed ID: 9918578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-oxides of phenothiazine antipsychotics: effects on in vivo and in vitro estimates of dopaminergic function.
    Lewis MH; Widerlöv E; Knight DL; Kilts CD; Mailman RB
    J Pharmacol Exp Ther; 1983 Jun; 225(3):539-45. PubMed ID: 6134814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabis and amphetamine-induced stereotypy in rats.
    Gough AL; Olley JE
    J Pharm Pharmacol; 1975 Jan; 27(1):62-3. PubMed ID: 235624
    [No Abstract]   [Full Text] [Related]  

  • 29. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lergotrile mesylate: an in vivo dopamine agonist which blocks dopamine receptors in vitro.
    Kebabian JW; Calne DB; Kebabian PR
    Commun Psychopharmacol; 1977; 1(4):311-8. PubMed ID: 615694
    [No Abstract]   [Full Text] [Related]  

  • 31. MJ 9022: correlation between neuroleptic potential and stereotypy.
    Sathananthan GL; Sanghvi I; Phillips N; Gershon S
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):701-5. PubMed ID: 1208
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of certain drugs on amphetamine-induced stereotyped behavior and brain amphetamine levels in the rat.
    Lal S; Missala K; Sourkes TL; Feldmuller F
    Biol Psychiatry; 1974 Aug; 9(1):3-10. PubMed ID: 4156181
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on the mechanism of post-etorphine catalepsy. Modyfying effect of amphetamine, apomorphine and dihydroxy-phenylalanine (L-dopa) on etorphine-induced concentrations of dopamine and noradrenaline in the rat central nervous system.
    Kania BF
    Acta Physiol Pol; 1979; 30(2):279-87. PubMed ID: 572616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of parachlorophenylalanine, mianserine and danitracen with amphetamine.
    Chodera A; Cenajek D; Mazurek K
    Arzneimittelforschung; 1981; 31(1):61-3. PubMed ID: 6452129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances.
    Sikiric P; Jelovac N; Jelovac-Gjeldum A; Dodig G; Staresinic M; Anic T; Zoricic I; Rak D; Perovic D; Aralica G; Buljat G; Prkacin I; Lovric-Bencic M; Separovic J; Seiwerth S; Rucman R; Petek M; Turkovic B; Ziger T; Boban-Blagaic A; Bedekovic V; Tonkic A; Babic S
    Acta Pharmacol Sin; 2002 May; 23(5):412-22. PubMed ID: 11978191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopaminergic antagonism of L-5-hydroxytryptophan-induced myoclonic jumping behavior.
    Weiner WJ; Carvey PM; Nausieda PA; Klawans HL
    Neurology; 1979 Dec; 29(12):1622-5. PubMed ID: 41197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of carbon disulphide on the stereotypic effect of dopamine agonists.
    Magos L
    Eur J Pharmacol; 1976 Mar; 36(1):257-8. PubMed ID: 944133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interactions of bromocriptine and lergotrile with dopamine and alpha-adrenergic receptors.
    Lew JY; Hata F; Ohashi T; Goldstein M
    J Neural Transm; 1977; 41(2-3):109-21. PubMed ID: 21229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification by antihypertensive drugs of amphetamine-induced stereotypy in rats.
    van Dorsser W; Roba J
    Arch Int Pharmacodyn Ther; 1979 Dec; 242(2):326-8. PubMed ID: 575615
    [No Abstract]   [Full Text] [Related]  

  • 40. Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrile.
    Teychenne PF; Rosin AJ; Plotkin CN; Calne DB
    Br J Clin Pharmacol; 1980 Jan; 9(1):47-50. PubMed ID: 6101955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.